Model DetailsUterus - Endometrium hyperplasia - cystic
Model Name |
Uterus - Endometrium hyperplasia - cystic | Strain |
CD-1 |
Tumor Inducing Agent(s) |
Hormone : diethylstilbestrol (DES) |
Tumor Synonyms |
cystic endometrial hyperplasia of the uterus • uterine cystic endometrial hyperplasia |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Uterus - Endometrium | Female |
50% (1 of 2 mice) |
15 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
4.8% (1 of 21 mice) |
12-17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
100% (1 of 1 mice) |
14 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
75% (3 of 4 mice) |
18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
21% (4 of 19 mice) |
12-18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
observed |
17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
observed |
18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
47% (8 of 17 mice) |
13-18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
observed |
17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
observed |
18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
41% (9 of 22 mice) |
13-18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
observed |
12 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
observed |
13 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
observed |
17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
observed |
18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
63% (22 of 35 mice) |
12-18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
observed |
12 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
observed |
13 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
100% (1 of 1 mice) |
14 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
100% (1 of 1 mice) |
17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Endometrium | Female |
60% (12 of 20 mice) |
12-17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |